Green Cures & Botanical Distribution (OTC PINK: GRCU) is pleased to announce through “Original Hollywood Hemp” a new joint venture with “Chronic Candy” www.chroniccandy.com. Chronic Candy is a pioneer and a respected leader in the Hemp and CBD edibles industry.
Together, GRCU and Chronic Candy will develop a new line of CBD Infused Edibles and Lollipops under a new brand name to be announced in the very near future. Chronic Candy has created a new blend of powerful CBD & terpene infused edibles. Using a mixture of PURE 99% CBD Isolate and a combination of true terpenes, the company is able to replicate the entourage effects and benefits for these CBD edibles to provide a safe and healthy alternative to access the many benefits of CBD.
Chronic Candy is an established and well-known name across the country. This is the original CBD lollipop that has been distributed across the nation for the last 15 years. The new line of products will hold the same quality standards as before, but provide a new spectrum of flavors & effects thanks to the added terpenes & cannabinoids.
The original CBD lollipop has used hemp based CBD oil for years. This new combination of pure CBD & terpenes will allow for additional entourage effects. These entourage effects will provide a series of added medicinal benefits.
The founder of Chronic Candy, Tony Van Pelt — “We are excited to form this new joint venture with GRCU under ‘Original Hollywood Hemp’ in the development of this new line of edibles & lollipops. This new alliance represents our strong commitment to provide consumers and shareholders the best in ingredients and will continue to provide top quality products.” Mr. Van Pelt further stated, “This joint venture will capitalize on the strong reputation Chronic Candy has built well over the past decade.”
GRCU understands this is an exciting growth opportunity in a dynamic category, and will capitalize on the complementary strengths and innovative expertise from Tony Van Pelt’s strong and successful brand and experience in this unique category. The company believes this new venture provides opportunities for both companies to grow and expand in this arena while enhancing shareholder value. GRCU and Chronic Candy view the new joint venture as a natural evolution which will drive a significant presence in this sector by enhancing our product offerings and services ultimately benefiting our consumers and shareholders across the nation.
Green Cures & Botanical Distribution Inc. (GRCU) develops, produces & distributes premium hemp based products in the following categories: Medical, Skin Care, Beauty, Fashion and lifestyle goods branded under the Original Hollywood Hemp™ Brand. Green Cures & Botanical Distribution Inc. (GRCU) also develops beverages branded under the Iconic Beverages ™ and others.
Green Cures & Botanical Distribution Inc., is revenue-generating company that wholesales and retails hemp-infused nutritional, botanical, sports, and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc., operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production and distribution, Green Cures & Botanical Distribution Inc., is continuously creating and introducing products that promote a healthy life style. For more information visit: http://www.originalhollywoodhemp.com/.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

CONTACT:
Green Cures & Botanical Distribution Inc.
instepholdingsllc@gmail.com

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less